|
gptkbp:instanceOf
|
gptkb:brand
gptkb:drug
|
|
gptkbp:abbreviation
|
Aptensio Extended Release
|
|
gptkbp:activeIngredient
|
methylphenidate hydrochloride
|
|
gptkbp:approvedBy
|
gptkb:FDA
|
|
gptkbp:ATCCode
|
N06BA04
|
|
gptkbp:broadcastOn
|
gptkb:Schedule_II_controlled_substance
|
|
gptkbp:contraindication
|
gptkb:glaucoma
MAOI use
tics
|
|
gptkbp:form
|
10 mg
20 mg
40 mg
50 mg
15 mg
70 mg
30 mg
extended-release capsule
60 mg
|
|
gptkbp:genericName
|
gptkb:methylphenidate
|
|
gptkbp:halfLife
|
3-4 hours
|
|
gptkbp:indication
|
ADHD in patients 6 years and older
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:manufacturer
|
Rhodes Pharmaceuticals
|
|
gptkbp:marketedAs
|
2015
|
|
gptkbp:mechanismOfAction
|
gptkb:stimulant
|
|
gptkbp:pregnancyCategory
|
C (US)
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
headache
nervousness
insomnia
decreased appetite
increased blood pressure
|
|
gptkbp:usedFor
|
gptkb:attention_deficit_hyperactivity_disorder
|
|
gptkbp:bfsParent
|
gptkb:methylphenidate
|
|
gptkbp:bfsLayer
|
8
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Aptensio XR
|